摘要 |
The invention relates to monoclonal antibodies (mAbs) that bind to transferrin (TF) and transferin receptor 1 (TFRC), hybridoma lines that secrete these antibodies, and the use of these antibodies to detect TF and TFRC antigens- Methods and uses for detecting cancer and iron deficiency anemia, as well as methods and uses for distinguishing between early and late stage prostate cancer are encompassed. |